Colorectal Cancer Screening Improvement Strategies at Geisinger

This document is a case study detailing the strategies implemented by Geisinger Health System to improve colorectal cancer (CRC) screening rates. It outlines the challenges faced during the COVID-19 pandemic, which led to a backlog of patients needing preventive screenings. The case study describes a systematic approach adopted by Geisinger’s primary care team, which involved leveraging electronic health records (EHR) and engaging internal stakeholders to facilitate the offering of multitarget stool DNA (mt-sDNA) screening as a noninvasive option for average-risk patients. Key strategies included optimizing EHR workflows, standardizing patient engagement tools, and establishing ongoing communication among clinical and operational teams. The document also discusses the importance of internal stakeholder engagement to align efforts across various departments. Through these initiatives, Geisinger aimed to enhance patient outreach and ultimately increase CRC screening rates, which have reportedly reached 70%.